Intervention and Education in Diabetes: A Pilot Project Comparing Usual Care with Pharmacist-Directed Collaborative Primary Care

Abstract

Background:

Prior to this project, patients were required to drive up to 2 hours to a diabetes education centre. As a result, many patients were not receiving diabetes education, and there was little or no follow-up of patients. Significant opportunity exists for pharmacists to fill such gaps in chronic disease management services.

Methods:

Patients were randomly assigned to the intervention or usual care arm. Laboratory data (glycosylated hemoglobin, fasting blood glucose, lipid panel, microalbumin, systolic and diastolic blood pressure) and Diabetes Empowerment Scale short form (DES-SF) score were collected at baseline and at 6 months. Intervention patients received a medication review, 3 one-on-one education sessions with one of the study pharmacists and follow-up phone calls. Usual care patients did not receive medication reviews or education sessions, and received follow-up phone calls only if drug-related problems were detected. Drug-related problems were tracked for all patients. Referrals to other health care professionals (dietitian, homecare, public health) were made as required. Paired-sample t-tests were used to compare baseline and 6-month data.

Results:

Forty-five patients were enrolled in the study (intervention: 23; usual care: 17). Five patients were lost to follow-up (intervention: 2; usual care: 3). There was a statistically significant improvement in DES-SF score in the intervention group (p < 0.001) and a decline in DES-SF score in the usual care group (p < 0.04). There was a significant decrease in glycosylated hemoglobin in the usual care group (p < 0.04). Referrals to other health care professionals were higher in the intervention group (I: 36; UC: 0). The number of drug-related problems detected was also greater in the intervention group (I: 83; UC: 8). The overall acceptance rate of pharmacist recommendations for drug-related problems was high in both arms (I: 81%; UC: 100%).

Conclusions:

Most outcome measures were not statistically significant. Further study is needed to evaluate the change in clinical outcomes. However, greater involvement of a pharmacist in diabetes management resulted in greater detection of drug-related problems and referral to other health care professionals, and promoted diabetes-related self-efficacy and appropriate self-care behaviour. Pharmacists can play an important role in the management of diabetic patients.

Get full access to this article

View all access options for this article.

References

Healthy Canadians: a federal report on comparable health indicators 2004. Ottawa (ON): Health Canada. Available: www.hc-sc.gc.ca/hcs-sss/pubs/system-regime/2004-fed-comp-indicat/table1_e.html (accessed September 23, 2008).

Ohinmaa

Jacobs

Simpson

The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Can J Diabetes 2004;28:116–23.

Task Force on Community Preventive Services

Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. MMWR Recomm Rep 2001;50 (RR16):1–15. Available: www.cdc.gov/mmwr/preview/mmwrhtml/rr5016a1.htm (accessed October 17, 2008).

Canadian Diabetes Association

UK Prospective Diabetes Study (UKPDS) Group

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.

Diabetes Control and Complications Trial Research Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

McDaniel

Gay

JT.

Diabetes self-care knowledge, behaviors, and metabolic control of older adults — the effect of a post-educational follow-up program. Diabetes Educ 1993;19:25–30.

Brown

SA.

Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revisited. Patient Educ Couns 1990;16:189–215.

Tarry

Diabetes management evaluation [report]. Wynyard (SK): Wynyard Community Health Centre; August 30, 2004.

10.

Harris

Ékoé

Zdanowicz

Webster-Bogaert

Glycemic control and morbidity in the Canadian primary care setting (results of the Diabetes in Canada Evaluation Study). Diabetes Res Clin Pract 2005;70:90–7.

11.

Lee

SSC

Cheung

Chow

MSS.

Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol 2004;44:632–9.

12.

Tsuyuki

Johnson

Teo

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149–55.

13.

Taylor

Semchuk

Deschamps

Pharmacist intervention in risk reduction study in high-risk cardiac patients: the effect of 2 methods of pharmacist training. Can Pharm J 2007;140:116–23.

14.

Cranor

Bunting

Christensen

DB.

The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:173–84.

15.

Coast-Senior

Kroner

Kelley

Trilli

LE.

Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636–41.

16.

Lee

VWY

Leung

PY.

Glycemic control and medication compliance in diabetic patient in a pharmacist-managed clinic in Hong Kong. Am J Health Syst Pharm 2003;60:2593–6.

17.

Romanow

chair.

Building on values: the future of health care in Canada. Saskatoon, SK: Commission on the Future of Health Care in Canada; 2002.

18.

Fyke

KJ.

Caring for Medicare: sustaining a quality system. Regina (SK): Commission on Medicare; 2001.

19.

Neubauer

Shevchuk

YM.

The Pharmacist as a Primary Health Care Team Member: A comparison of usual care versus pharmacists in primary care practices on the acceptance and appropriateness of pharmacists' recommendations and patients outcomes. Unpublished presentation. Primary Health Services Branch and Saskatchewan Prescription Drugs Program of Saskatchewan Health; August 2003.

20.

Anderson

Fitzgerald

Gruppen

LD.

The Diabetes Empowerment Scale — Short Form (DES-SF). Diabetes Care 2003:26:1641–2.

21.

Friedewald

Levy

Fredrickson

. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18 (6):499–502.

22.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee

Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;27 Suppl 2: S1–S152.